![](https://www.Immune-System-Research.com/"wp-content/uploads"/2021/06/Simeprevir-is-an-Orally-Active-HCV-NS34A-Protease-Inhibitor-2021-06-19.jpg)
Hepatitis C is a blood-borne infection that can ultimately result in severe liver diseases, including fibrosis, cirrhosis, and hepatocellular carcinoma.…
![](https://www.Immune-System-Research.com/"wp-content/uploads"/2021/03/AT-527-is-a-Potent-and-Orally-Active-HCV-Viral-Replication-Inhibitor-2021-03-13.jpg)
There are approximately 71 million people globally who are chronically infected with the hepatitis C virus (HCV). The chronic infection…
![](https://www.Immune-System-Research.com/"wp-content/uploads"/2021/01/AG-1478-is-a-Selective-EGFR-Tyrosine-Kinase-Inhibitor-2020-01-16.jpg)
Epidermal growth factor receptor (EGFR) is a transmembrane protein and a member of the ErbB receptor family. Specifically, EGFR is…
![](https://www.Immune-System-Research.com/"wp-content/uploads"/2020/12/BMS-986144-is-a-Third-Generation-NS34A-Protease-Inhibitor-2020-01-07.jpg)
Hepatitis C virus (HCV) is a human pathogen with high morbidity. The HCV NS3/4A protease is essential for viral replication…
![](https://www.Immune-System-Research.com/"wp-content/uploads"/2020/02/BI-1230-is-a-Digit-Nanomolar-HCV-NS3-Protease-and-Viral-Replication-Inhibitor-2020-02-19.jpg)
BI-1230 is a potent and digit nanomolar inhibitor of HCV NS3 protease and of viral replication. BI-1230 is also highly…